HOME >> MEDICINE >> NEWS
Solution to bacterial mystery promises new drugs

A 25-year quest to identify the first biochemical step that many disease-causing bacteria use to build their membranes has led to a discovery that holds promise for effective, new antibiotics against these bacteria, according to investigators at St. Jude Children's Research Hospital. The finding is significant because the biochemical step the antibiotic would block is not used by humans. Therefore, such a drug would not cause dangerous side effects.

A report on this finding appears in the September 1 issue of Molecular Cell.

The discovery also demonstrated that current textbooks use the wrong type of bacterium as a model to explain a critical biochemical step that most disease-causing bacteria use to make their membranes, according to Charles Rock, Ph.D., a member of the St. Jude Department of Infectious Diseases and senior author of the paper. As bacteria grow in size or divide, they must make additional membrane using a series of biochemical reactions. The first step in this process is the transfer of a fatty acid to a molecule called G3P. Bacteria then convert this molecule into a variety of other molecules called phospholipids, which are the building blocks of membranes.

"We identified a biochemical process that uses a previously unrecognized molecule as a raw material to make phospholipid," Rock said. "That discovery solved a mystery that has puzzled researchers for 25 years."

Scientists have used E. coli bacteria for many years as a model to understand how disease-causing bacteria make membrane phospholipids, but E. coli is an unsuitable model for most pathogens (disease-causing bacteria), according to Rock.

First, E. coli is a so-called gram-negative bacterium, while many of the pathogens researchers are interested in are gram-positive, Rock noted. Among those gram-positive organisms are Staphylococcus aureus, which causes skin infections and serious blood infections, and Streptococcus pneumoniae, which causes pneumoni
'"/>

Contact: Bonnie Kourvelas
bonnie.kourvelas@stjude.org
901-495-4815
St. Jude Children's Research Hospital
31-Aug-2006


Page: 1 2

Related medicine news :

1. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
2. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
3. Researchers discover how antibiotic inhibits bacterial growth
4. Penn study on lung-infecting bacterial enzyme suggests new approach to cystic fibrosis treatment
5. Clinical guidelines help identify which children at risk of bacterial meningitis
6. Researchers identify new weapon to fight deadly bacterial sepsis
7. Antibacterial coatings cut infection rates
8. A fast diagnosis for bacterial meningitis
9. Effects of bacterial pneumonia no worse for HIV-positive patients
10. A virus-like hitchhiker may trigger bacterial meningitis
11. Hormonal birth control, bacterial infections in women linked to increased shedding of type-2 herpes

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/7/2020)... ... January 07, 2020 , ... ... for characterizing microbiome populations down to the strain level, has announced a ... organization. , TOMY provides high-quality instruments and services to industry segments including ...
(Date:1/7/2020)... ... January 07, 2020 , ... Red Oak ... Director of Foothills at Red Oak Recovery effective immediately. Ian began working ... the nation's leading residential treatment centers for adolescents. In this capacity, Ian worked ...
(Date:1/7/2020)... ... 06, 2020 , ... After 32 years in Stealth Mode, LumaCare ™ ... Duo ™. , The first public demonstrations of the LumaCare Duo will be given ... during CES 2020, the largest consumer electronics trade show and conference in the United ...
(Date:1/7/2020)... ... , ... R3 Stem Cell is now offering access to all regenerative training ... 24/7 and includes all the stem cell and exosome courses. , For several years, ... For the online regenerative training courses, R3 assembled all of the presentations and procedures ...
(Date:1/3/2020)... ... January 02, 2020 , ... ... lifestyle solutions, has announced the final round of U.S. finalists for its annual ... are Andrew Bischoff of Minnetonka, Minnesota; Ashley Pederson of St. Paul, Minnesota; Kim ...
Breaking Medicine News(10 mins):
(Date:1/7/2020)... , ... January 07, 2020 , ... ... enterprises and telecom service providers, announced today it has been selected by MetLife ... network infrastructure. , “As part of our ongoing commitment to maintain the ...
(Date:1/5/2020)... ... January 04, 2020 , ... The Voice First ... firms are fighting for leadership in both devices and voice assistant software. As ... during the past few years, multiple health-related voice assistants have been introduced, including ...
(Date:1/3/2020)... ... ... Stay on top of current hot topics through free webinars presented by leading ... free, so be sure to register today to save your place. Participate in the ... our upcoming webinars: , CLINICAL OPERATIONS , January 23 – The Benefits of a ...
Breaking Medicine Technology:
Cached News: